Afuco™ Anti-HBV ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-746) (CAT#: AFC-TAB-746)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to HBV. It is a human monoclonal antibody developed for the treatment of hepatitis B infections.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • HBV
  • Applications
  • FC, IP, ELISA, Neut, FuncS, IF
  • Conjugate
  • Unconjugated
  • Trade name
  • Hepex-B
  • Generic Name
  • Exbivirumab
  • Related Disease
  • Hepatitis B reinfection in liver transplant patients

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • HBV; Major surface antigen

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "exbivirumab"

Anti-HBV Recombinant Antibody (Exbivirumab)
Recombinant human monoclonal antibody expressed in CHO binding to HBV. Exbivirumab is a human monoclonal antibody developed for the treatment of hepatitis B infections.
DrugMonitor™ Anti-Exbivirumab Antibody (VS-1224-YC461)
Exbivirumab is an investigational monoclonal antibody used in HepeX-B, a drug containing two human monoclonal antibodies targeting the hepatitis B virus (HBV) surface antigen. The DrugMonitor™ Anti-Exbivirumab Antibody (VS-1224-YC461) is an anti-drug antibody (ADA) against Exbivirumab. This drug-based antibody is raised in mice immunized with the Exbivirumab. The anti-Exbivirumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Exbivirumab in samples.

See other products for "HBV"

Select a product category from the dropdown menu below to view related products.
Please select product type
Single Domain Antibody Products Human Antibody Products Fab Antibody Products Humanized Antibody Products Mouse Antibody Products MHC Tetramer Products for Virology IgG Antibody Products ScFv Antibody Products ADCC Enhanced Antibody Products ScFv-Fc Chimera Products
CAT Product Name Application Type
NAB-1234-sdAb Recombinant Anti-HBV VHH Single Domain Antibody IHC, IP, FC, Neut, FUNC Llama VHH

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-746. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare